InsidersTradesSigma
Track the 博拓生物 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 博拓生物 has logged 4 insider filings. Market capitalisation: €5.2bn. The latest transaction was disclosed on 8 May 2025 (Sale). Among the most active insiders: 高红梅. All data is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€249,397
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,617 of 29,064 companies
51.9
score / 100
Value37
Quality67
FCF yld-0.5%
Earn yld1.0%
EV/EBITDA·
ROE1.2%
Gross mgn46%
Net mgn11%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 May 2025
关于 博拓生物
博拓生物是一家专注于医疗保健和制药领域的公司，在XSHG市场上市。该公司致力于开发创新的生物制药解决方案。